Clin2
NCT05255926Possibly a fitRecruiting

CXCR4 scan test using PET/CT for blood cancers

CXCR4PET/CTHematological Malignancy

Treatments studied

Part of Blood & lymphatic, Cancer clinical trials.

This trial looks at an imaging scan called CXCR4-targeted PET/CT to help doctors see certain blood cancers. You may be helped by getting clearer information about where cancer is in your body, and the results may guide future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • Be willing to sign an informed consent form
  • Be between 18 and 90 years old
  • Have a suspected, newly diagnosed, or relapsed blood cancer
  • Be able to attend required visits and complete blood tests and scans
  • Be able to complete the PET/CT scan lying still and manage claustrophobia or fear of radiation

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07385950Not yet recruiting
New imaging test for solid tumors

This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.

Wuhan, Hubei
NCT07487883Recruiting
PET scan for lung cancer using a special tracer

This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.

Beijing, Beijing Municipality
NCT06690736Recruiting
CXCR4 PET/CT imaging for related conditions

This trial uses a special imaging scan (CXCR4 PET/CT) to help diagnose or evaluate certain diseases linked to a protein called CXCR4. It may offer more detailed information than standard scans.

Hefei, Anhui
NCT05093335Recruiting· Early Phase 1
PET scan test for CXCR4 in many relapsed cancers

This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.

New York, New York
NCT07122674Recruiting
New PET scan for blood cancers

This study tests a new PET scan method (using a special tracer called 18F-Pentixafor) to see if it can better find and track blood cancers. It may help your doctors get more detailed images with less radiation.

Hangzhou, Zhejiang
NCT04504526Recruiting· Early Phase 1
New imaging for diagnosing lymphoma

This study tests a new imaging method called CXCR4 PET/CT that may help doctors better see and understand lymphomas (a type of blood cancer). It is for people who are newly diagnosed or suspected of having lymphoma and have already had a standard PET/CT.

Fuzhou, Fujian

Hear when a new PET/CT trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.